Stock Traders Purchase High Volume of Call Options on ARK Genomic Revolution ETF (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) was the target of unusually large options trading on Tuesday. Stock traders bought 32,950 call options on the stock. This represents an increase of 125% compared to the average daily volume of 14,663 call options.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Hemington Wealth Management boosted its position in shares of ARK Genomic Revolution ETF by 44.6% during the fourth quarter. Hemington Wealth Management now owns 1,310 shares of the company’s stock worth $30,000 after buying an additional 404 shares during the period. Union Bancaire Privee UBP SA acquired a new stake in shares of ARK Genomic Revolution ETF in the fourth quarter valued at $45,000. BNP Paribas acquired a new stake in shares of ARK Genomic Revolution ETF in the fourth quarter valued at $47,000. National Bank of Canada FI raised its stake in shares of ARK Genomic Revolution ETF by 28.4% in the third quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after acquiring an additional 920 shares in the last quarter. Finally, ARK Investment Management LLC raised its stake in shares of ARK Genomic Revolution ETF by 72.7% in the fourth quarter. ARK Investment Management LLC now owns 5,989 shares of the company’s stock valued at $141,000 after acquiring an additional 2,521 shares in the last quarter.

ARK Genomic Revolution ETF Stock Up 24.9 %

Shares of ARKG traded up $5.88 during midday trading on Tuesday, hitting $29.49. 4,900,270 shares of the stock were exchanged. The stock’s 50-day moving average is $25.66 and its two-hundred day moving average is $25.29.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.